Erratum to: RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6 (Nature, (2018), 557, 7706, (564-569), 10.1038/s41586-018-0118-y);RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6

Nature

Volumn 557, Issue 7706, 2018, Pages 564-569

  Szenker Ravi, Emmanuelle ^a   Altunoglu, Umut ^b   Leushacke, Marc ^a   Bosso Lefèvre, Célia ^a,c   Khatoo, Muznah ^a   Thi Tran, Hong ^d   Naert, Thomas ^d   Noelanders, Rivka ^d   Hajamohideen, Amin ^a   Beneteau, Claire ^e   De Sousa, Sergio B ^f,g   Karaman, Birsen ^b   Latypova, Xenia ^e   Başaran, Seher ^b   Yücel, Esra Börklü ^h   Tan, Thong Teck ^a   Vlaminck, Lena ^d   Nayak, Shalini S ⁱ   Shukla, Anju ⁱ   Girisha, Katta Mohan ⁱ   Le Caignec, Cédric ^e,j   Soshnikova, Natalia ^k   Uyguner, Zehra Oya ^b   Vleminckx, Kris ^d,p   Barker, Nick ^a,l,m   Kayserili, Hülya ^b,h   Reversade, Bruno ^a,c,h,n,o   more..

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GHENT UNIVERSITY   (Belgium)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^g UNIVERSITY OF COIMBRA   (Portugal)

^h KOÇ UNIVERSITY   (Turkey)

ⁱ KASTURBA MEDICAL COLLEGE   (India)

^j INSERM   (France)

^k Institute of Molecular Biology gGmbH (IMB)   (Germany)

^l KANAZAWA UNIVERSITY   (Japan)

^m UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁿ INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^o ACADEMIC MEDICAL CENTER   (Netherlands)

^p GHENT UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6; LEUCINE; RING FINGER PROTEIN; WNT PROTEIN; DNA BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; LGR4 PROTEIN, HUMAN; LGR5 PROTEIN, HUMAN; LGR6 PROTEIN, HUMAN; ONCOPROTEIN; R-SPONDIN2 PROTEIN, HUMAN; RNF43 PROTEIN, HUMAN; SIGNAL PEPTIDE; UBIQUITIN PROTEIN LIGASE; ZNRF3 PROTEIN, HUMAN;

ALLELE; BIOLOGICAL DEVELOPMENT; CANCER; CELL; CHEMICAL BINDING; GENETIC ANALYSIS; INHIBITION; LIGAND; MEDICINE; MUTATION; RESPIRATORY DISEASE; RODENT;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; EMBRYO; FEMALE; FETUS; GENE; GENE DELETION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; LGR4 GENE; LGR5 GENE; LGR6 GENE; LIMB DEFECT; LIMB DEVELOPMENT; LUNG AGENESIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; RSPO2 GENE; SIGNAL TRANSDUCTION; XENOPUS; ANIMAL; ANTAGONISTS AND INHIBITORS; DEFICIENCY; EMBRYOLOGY; FIBROBLAST; GENE KNOCKOUT; GENETICS; HEK293 CELL LINE; LIMB; LIMB MALFORMATION; METABOLISM;

MUS;

ANIMALS; DNA-BINDING PROTEINS; EXTREMITIES; FEMALE; FIBROBLASTS; GENE KNOCKOUT TECHNIQUES; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIMB DEFORMITIES, CONGENITAL; MALE; MICE; ONCOGENE PROTEINS; PHENOTYPE; RECEPTORS, G-PROTEIN-COUPLED; UBIQUITIN-PROTEIN LIGASES; XENOPUS;

EID: 85047253329     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-018-0296-7     Document Type: Erratum

References (44)

1. de Lau, W. et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476, 293-297 (2011).
2. Glinka, A. et al. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep. 12, 1055-1061 (2011).
3. Carmon, K. S., Gong, X., Lin, Q., Thomas, A. & Liu, Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling. Proc. Natl Acad. Sci. USA 108, 11452-11457 (2011).
4. Niswander, L. Pattern formation: old models out on a limb. Nat. Rev. Genet. 4, 133-143 (2003).
5. Niemann, S. et al. Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. Am. J. Hum. Genet. 74, 558-563 (2004).
6. Kazanskaya, O. et al. R-Spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis. Dev. Cell 7, 525-534 (2004).
7. Kim, K. A. et al. R-Spondin proteins: a novel link to β-catenin activation. Cell Cycle 5, 23-26 (2006).
8. Nam, J. S., Turcotte, T. J., Smith, P. F., Choi, S. & Yoon, J. K. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate β-catenin-dependent gene expression. J. Biol. Chem. 281, 13247-13257 (2006).
9. Ohkawara, B., Glinka, A. & Niehrs, C. Rspo3 binds syndecan 4 and induces Wnt/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis. Dev. Cell 20, 303-314 (2011).
10. Zebisch, M. et al. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat. Commun. 4, 2787 (2013).
11. Bell, S. M. et al. R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development 135, 1049-1058 (2008).
12. Aoki, M., Kiyonari, H., Nakamura, H. & Okamoto, H. R-spondin2 expression in the apical ectodermal ridge is essential for outgrowth and patterning in mouse limb development. Dev. Growth Differ. 50, 85-95 (2008).
13. Nam, J. S. et al. Mouse R-spondin2 is required for apical ectodermal ridge maintenance in the hindlimb. Dev. Biol. 311, 124-135 (2007).
14. Yamada, W. et al. Craniofacial malformation in R-spondin2 knockout mice. Biochem. Biophys. Res. Commun. 381, 453-458 (2009).
15. Brüchle, N. O. et al. RSPO4 is the major gene in autosomal-recessive anonychia and mutations cluster in the furin-like cysteine-rich domains of the Wnt signaling ligand R-spondin 4. J. Invest. Dermatol. 128, 791-796 (2008).
16. Başaran, S. et al. Tetra-amelia, lung hypo-/aplasia, cleft lip-palate, and heart defect: a new syndrome? Am. J. Med. Genet. 51, 77-80 (1994).
17. Sousa, S. B. et al. Tetra-amelia and lung hypo/aplasia syndrome: new case report and review. Am. J. Med. Genet. A. 146A, 2799-2803 (2008).
18. Xie, Y. et al. Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. EMBO Rep. 14, 1120-1126 (2013).
19. Proffitt, K. D. et al. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res. 73, 502-507 (2013).
20. Mazerbourg, S. et al. Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality. Mol. Endocrinol. 18, 2241-2254 (2004).
21. Morita, H. et al. Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension. Mol. Cell. Biol. 24, 9736-9743 (2004).
22. Snippert, H. J. et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385-1389 (2010).
23. Styrkarsdottir, U. et al. Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497, 517-520 (2013).
24. Sulem, P. et al. Identification of a large set of rare complete human knockouts. Nat. Genet. 47, 448-452 (2015).
25. Koizumi, M. et al. Lgr4 controls specialization of female gonads in mice. Biol. Reprod. 93, 90 (2015).
26. Jin, Y. R., Turcotte, T. J., Crocker, A. L., Han, X. H. & Yoon, J. K. The canonical Wnt signaling activator, R-spondin2, regulates craniofacial patterning and morphogenesis within the branchial arch through ectodermal-mesenchymal interaction. Dev. Biol. 352, 1-13 (2011).
27. Aoki, M. et al. R-spondin3 is required for mouse placental development. Dev. Biol. 301, 218-226 (2007).
28. van de Glind, G. C. et al. RNA-seq analysis of Lgr6+ stem cells and identification of an Lgr6 isoform. Exp. Dermatol. https://doi.org/10.1111/ exd.13453 (2017).
29. Lebensohn, A. M. & Rohatgi, R. R-spondins can potentiate WNT signaling without LGRs. eLife 7, e33126 (2018).
30. Simon, A. & Tanaka, E. M. Limb regeneration. Wiley Interdiscip. Rev. Dev. Biol. 2, 291-300 (2013).
31. Hao, H. X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195-200 (2012).
32. Koo, B. K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665-669 (2012).
33. Seshagiri, S. et al. Recurrent R-spondin fusions in colon cancer. Nature 488, 660-664 (2012).
34. Bond, C. E. et al. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget 7, 70589-70600 (2016).
35. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
36. Wang, D. et al. Structural basis for R-spondin recognition by LGR4/5/6 receptors. Genes Dev. 27, 1339-1344 (2013).
37. Peng, W. C. et al. Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Reports 3, 1885-1892 (2013).
38. Li, S. J. et al. Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function. Cell. Signal. 21, 916-925 (2009).
39. Krug, U., Patzschke, R., Zebisch, M., Balbach, J. & Sträter, N. Contribution of the two domains of E. coli 5′-nucleotidase to substrate specificity and catalysis. FEBS Lett. 587, 460-466 (2013).
40. Monsoro-Burq, A. H. A rapid protocol for whole-mount in situ hybridization on Xenopus embryos. CSH Protoc. 2007, pdb.prot4809 (2007).
41. Van Nieuwenhuysen, T. et al. TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis. Oncoscience 2, 555-566 (2015).
42. Naert, T., Van Nieuwenhuysen, T. & Vleminckx, K. TALENs and CRISPR/Cas9 fuel genetically engineered clinically relevant Xenopus tropicalis tumor models. Genesis 55, https://doi.org/10.1002/dvg.23005 (2017).
43. Moreno-Mateos, M. A. et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 12, 982-988 (2015).
44. Boel, A. et al. BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment. Sci. Rep. 6, 30330 (2016).